Dtc At The Crossroads

Loading...

Flash Player 9 (or above) is needed to view presentations.
We have detected that you do not have it on your computer. To install it, go here.

0 comments

Post a comment

    Post a comment
    Embed Video
    Edit your comment Cancel

    Favorites, Groups & Events

    Dtc At The Crossroads - Presentation Transcript

    1. DTC Mar ke ting at the Cros sroa ds Richard Meyer Internet Marketing Consulting in Health October 2009
    2. Healthcare is under scrutiny •  America is 37th in the world in terms of healthcare performance •  We rank 18th out of 18 in industrialized countries •  62% of all bankruptcies were directly caused by medical bills •  18% of our GDP was spent on healthcare in 2008 •  75% of healthcare dollars are spent on mostly preventable chronic diseases.
    3. Including intense media scrutiny
    4. But the outlook for the drug industry remains positive •  The global market for pharmaceuticals is expected to grow 4 to 6% in 2010 – exceeding $825 billion –  The forecast also predicts 4-7% growth over the next five years •  The total pharmaceutical market is expected to reach $975 billion or more by 2013 •  The $137 billion lost to patent expiries (Lipitor, Plavix and Seretide, for example) over the next five years will still be a challenge. The outlook reflects “a greater resilience to economic slowdown [in the US],” as well as growth in emerging markets, like China.
    5. Even with a projected rise in sales, the drug industry is under a lot of pressure Generic     Prescrip(on  drug   Pa(ent   compe((on   prices     co-­‐payments   Physician   Increased  costs   budgets     of  prescrip(on  drug   development   Tougher   FDA   Healthcare   legisla(on   Empowered     Power  of     pa(ents   Insurers     Hos(le  news   Ineffec(veness  of   media   tradi(onal  marke(ng  
    6. Many challenges remain, especially for DTC marketers
    7. The recession has led to a loss in trust in business Consumers don’t trust business
    8. Insurers and pharma take most of the blame for healthcare woes
    9. Yet prescription drugs represent only 10% of each healthcare dollar spent Costs  of  each  healthcare  dollar   Research;  2%   Equipment;  4%   Other;  12%   Dental  Care;  4%   Hospital  Care;   Admin  Costs;   31%   7%   Physician  &   clinical  services;   21%   Nursing  Home   Care;  9%   Prescrip(on   Drugs;  10%  
    10. With all of these environmental factors, did I mention that… R.I.P.   Tradi4onal   Marke4ng  
    11. Old media is in a steep decline According  to  Forrester   Research,  48%  of  consumers   now  believe  that  they  have   the  right  to  decide  whether   or  not  to  receive  adver(sing   The  drop  in  tradi(onal  media   is  driven  by  con(nued   migra(on  of  consumers  to   digital  alterna(ves  for  news,   on-­‐demand  entertainment,   and  informa(on,  which   requires  less  (me  than   tradi(onal  media   counterparts  
    12. People are flocking to social media With over half of the U.S. adult population consuming online video, it has evolved from an emerging format to a form of mainstream media. Manhattan Research 2009
    13. Traditional Segmentation doesn’t work anymore DTC Marketing at the Crossroads Demographics are dead, long live Tribes A small--but growing and passionate-- group of people are changing the face The message to marketers is clear: No of society. They may never grow larger single demographic, or even handful than 3 million people, or roughly 1% of of demographics, neatly defines the the U.S. population, but those people nation or a market. have unmet needs that they are passionate about. And 3 million passionate people are by far enough to make or break a business. "The average American has been There is no such thing as the replaced by a complex, “average American consumer” multidimensional society that defies simplistic labeling."
    14. Because people are clustering into Tribes (or microtrends) People  are  now   connected  via  the   Internet  by  choices   such  as;   -­‐similar  aUtudes   -­‐beliefs   -­‐lifestyles     -­‐aspira(ons  
    15. With the growth of connections via the Internet comes a more empowered patient
    16. As empowered patients gain more power DTC marketing is being cut Reasons DTC Marketing Spending is decreasing in 2009 According to US DTC pharma marketers. Budget cuts 48% Shift to targeted direct-to-patient 16% Shift to Health Care Professional 14% Shift to more persistence & adherence programs 9% Shift to Integrated, nonpersonal promotion 7% Source:  Cegedim  Dendrite,  2009  Direct-­‐to-­‐Consumers  Industry  Checkup  
    17. Senior executives are now asking “What is the real value of DTC marketing?” A DTC marketer’s worst nightmare?
    18. DTC ad spending is projected to be down again this year
    19. Even DTC marketers feel that DTC marketing is less effective Effec4veness  of  DTC  Marke4ng  in  2009  According    to  US  DTC  Pharma  Marketers   45%  More   55%   Effec(ve   Less  Effec(ve   Source:  Cegedim  Dendrite,  2009  Direct-­‐to-­‐Consumers  Industry  Checkup  
    20. And the hard reality is… •  Only 28% of DTC campaigns generate more than 1000 patients* •  Only 18% of traditional TV campaigns generate a positive ROI. •  Marketers are being asked to show proof that their marketing is working (hard ROI) *Nielsen  DTC  study,  February  2008  
    21. And with all this going on More  people  are  self  diagnosing  and  less  are  going  to  their  doctors.  
    22. And you wanted to get into DTC marketing !?
    23. What trends are empowering patients?
    24. Internet use for health is increasing steadily Since  2005,  the  number  of  pa4ents  using  the  Internet  to  research  prescrip4on  drug  informa4on  has  doubled  to   102.3  million.    
    25. More consumers relied on the internet for health information than their doctors in 2008
    26. Online health inquiries do have an impact on decisions and actions •  Six of 10 e-patients say their most recent search had an impact on their own health or the way they care for someone else: –  60% say the information found online affected a decision about how to treat an illness or condition –  56% say it changed their overall approach to maintaining their health or the health of someone they care for –  53% say it led them to ask a doctor new questions, or to get a second opinion from another doctor. Fully  42%  of  all  adults,  or  60%  of  e-­‐pa4ents,  say  they  or  someone  they   know  has  been  helped  by  following  medical  advice  or  health   informa4on  found  on  the  internet.    
    27. Patients are BLOGGING about their health experiences
    28. And diagnosed patients are using social media
    29. And use of social media for health is increasing every year
    30. OK, so people are using social media for health information, but can it work for DTC marketing?
    31. It depends on your company Risk Adverse Willing to manage risk
    32. The reality is •  People are having the conversation about your brand, company and treatment options. •  Do you want to be part of the conversation ?
    33. For example: Twitter Mom’s on Gardasil
    34. And the buzz around Enbrel via Twitter
    35. Google Wiki another voice for patients & consumers
    36. Should you care? Yes,  because  pharma  is  not  a    trusted  source  of  health  informa4on   How Americans search for health information On the Internet
    37. CPG marketers have heard the call and are shifting dollars to new media
    38. And the increases are broad
    39. What are pharma marketers waiting for?
    40. But the really big question is?
    41. Is pharma willing to embrace open branding ?
    42. Right now, most drug companies are closed brands
    43. More importantly… Can marketers persuade executives to embrace open branding?
    44. To make the case, start with the realities of marketing today Failure   Success  
    45. Marketing as we know it is no longer sustainable in its current form. Bob Gilbreath, Chief Marketing Strategist, Bridge Worldwide “The Next Evolution of Marketing” Pharmaceutical marketing is in trouble, not only because it is not as effective as it should be but also because the cost of marketing has spiraled out of control and has reached the point where most pharmaceutical companies are finding it unaffordable. Improving Return on Investment in Pharmaceutical Marketing-Spectrum 2008
    46. Its ironic that, as sales decrease and new drugs become harder to develop, more companies are choosing to cut marketing at a time when they really need marketing to drive business.
    47. The realities of today’s marketplace 1.  Increased internet penetration has led to more empowered patients and empowered patients are consumers of healthcare. 2.  Engagement is not a fad. It’s the way today’s consumers do business and evaluate treatment options and brands. 3.  Consumers/patients are sharing their experiences with your products via word-of-mouth and social media. 4.  A new, tougher FDA, with few guidelines on new media, emphasizes risks that are within corporate guidelines. 5.  Segmentation of your audience by demographics alone is not relevant. Segmentation by psychographics (tribes) means personally relevant patient messages. 6.  Lack of credibility and trust are hurting your marketing efforts.
    48. Traditional media is no longer sustainable for pharma •  Price and reimbursement controls •  Changing practices - limited time •  Public scepticism of the pharmaceutical industry and its impact on communication •  Legal issues facing pharma company communication strategies •  Adverse event reporting
    49. Empowered patients are changing everything, you need to…   Monitor social media buzz and quantify threats to your brand.   Develop a process for responding quickly to misinformation about your product/brand as well for accurate information that maybe taken out of context.   Don’t use push messaging channels; act as an aggregator for the brand/disease state/product to bring people together.   Inform and educate patients about ongoing clinical trials with your product and post results in easy to understand language.   Reach out to develop consumer KOLs   Use internal resources (medical people, KOLs) to answer patient questions within FDA guidelines.
    50. Because patients are sharing their experiences   No matter what you do or say, patients share their health experiences on the Internet.   Act as brand aggregator to bring people together   Don’t get in the middle of the conversation   Listen to what is being said, and what is driving the conversation.   Ask “what can we do to reach influentials ?”   Can you get patients to BLOG about your product?
    51. Mass Market segmentation is dead & Tribes are the new segmentation •  Tribes are the new communities that consumers want to belong to and participate in. •  Businesses must understand these tribes A  community  of  SSRI  users  on  Tribe.net   and decide which ones they are going to align themselves with to reflect their brands and attract customers over time. The  marketer  that  a[empts  to  reach  and  influence  everybody  will  end  up   reaching  and  influencing  nobody  
    52. A tougher, more political, FDA is now in control   Reach out to your medical, regulatory, and legal people. Let them know what other companies are doing and why.   Ensure they know that the marketplace is changing and why.   Remember they are not marketers, and they need to understand the “why” as well as the “how”.   Lay out a clear scenario of risk/reward (ROI) for everything, but acknowledge that traditional ROI measurement, by tactic, may be myopic.   Stay on top of FDA news and enforcement actions. Understand what the FDA is saying and why and explain it to your team.   The FDA may change (a meeting has been called for November to explore social media & health) but this change may be slow.
    53. Credibility issues still exist in pharma   Consumers don’t trust drug industry messages   The industry is taking a lot of blame for healthcare shortcomings.   Consumers may go to your product website, but they are going to your competitors websites and health portals to compare information.   Take your message to your audience where they are online and ensure that your key messages are consistent across the web.   Don’t ignore media news stories about your drug/brand. Weigh in with transparency using medical people.   The first step towards credibility has to be taken. Give it time, it is a long road.
    54. Life Cycle Management needs to play a bigger role in DTC decisions   What is awareness of the disease and its symptoms with your audience ?   Set awareness goals and when these goals are reached, reconsider the use of TV.   Focus on solutions to problems, not product benefits. “I should have done more” campaign for Lipitor clearly explains   Focus on the point-of-difference for the risks of high cholesterol and provides a solution for consumers your product.
    55. The days of really big DTC budgets maybe gone forever •  All marketing people are being asked to “do more with less” •  Company executives may see marketing as more of an expense. •  Measure everything you do with DTC, but also understand that the key metric that you’re going to be measured against is sales as business objectives supersede engagement metrics. •  Form a tighter relationship with your agencies and make them accountable for quantifiable metrics that can be measured (sales?) •  Don’t micromanage your agencies. You hired them because of their expertise, let them do what they do best. •  Integrate agency people into your team so they can understand your internal barriers and challenges. •  Good is the enemy of great. If you don’t have the dollars to do it great, then do something else.
    56. And with all these changes come..
    57. Measure and optimize continually   Evolve your message as conditions within the marketplace change   Change/evolve channels to ensure effective reach and frequency   Online marketing has to continually be updated to stay relevant. Ensure that you have a plan to update all online marketing initiatives.   Review your web analytics thoroughly to create a decision tree of how consumers are evaluating your brand/product.   Eliminate web content that is not being used by your audience. It’s about them, not your marketing.
    58. Use research to provide insights instead of support •  Instead of asking questions that reveal a consumers “intent to purchase” or “ask their doctor about your product,” DTC marketers need to break through the clutter to find out what is genuinely valuable to your target audience. •  Psychographics should be leveraged to develop marketing that engages consumers •  Don’t use research to overcome your fears •  The right question to ask is “why are we conducting this research?”
    59. Start building digital capabilities NOW •  Don’t just put one person in Internet marketing. •  Hire someone who understands how consumers use the Internet and who also has a great background in marketing health marketing. •  Don’t wait for the FDA to issue guidelines. Be willing to take agreed- upon risks. •  Ensure that your web analytics are being used to tell a story and identify opportunities for your brand/company. •  Stay on top of online marketing trends and learn from others who are blazing trails in tactics like social media. •  Best practices: one eMarketing person per brand whose focus is Internet marketing and only Internet marketing. •  As you have successes, share best practices within the organization so that marketers start asking “what if….?”
    60. If you really want to anticipate the future… •  Start thinking... how can we leverage the new Apple & Microsoft tablets? •  64% of U.S. physicians own smartphones, and this will increase to 81% penetration by 2012 •  Create customized DTC materials by physician that can be printed or e-mailed to patients on demand •  Help physicians help patients and you will enhance your brand. •  Think engagement... and how do we measure engagement? Now  is  the  4me  to  add  resources  to  build  capabili4es  
    61. Where  Do  Your  DTC  Marke4ng  Plans  Fall?  
    62. “It’s not about you” The first sentence of the best-selling hardback book in U.S. history, The Purpose Driven Life
    63. My passion is DTC Marketing •  Passion is the enthusiasm you have for something. It’s the thing you get energized just thinking about. It’s the topic you never get tired of learning about. It’s what you never get tired of talking about. It’s where your creativity soars. It’s being in that zone where you forget time, space, and even hunger because you are so engaged in what you are doing. •  My passion is connecting people with health information, ideas, opportunities and resources in order to see them get and stay healthy. •  It’s what I’ve been doing in some form across my career: as a teacher, trainer, online marketer, and now author. •  I love finding and sharing information. Where someone else may get bored or frustrated hunting down information, I relish the opportunity to find and share what I discover because in the end every success equals a difference in a patient’s life for the better. •  richardameyer@me.com
    SlideShare Zeitgeist 2009

    + Rich MeyerRich Meyer Nominate

    custom

    231 views, 0 favs, 0 embeds more stats

    DTC Marketing is facing a lot of challenges as is t more

    More info about this document

    © All Rights Reserved

    Go to text version

    • Total Views 231
      • 231 on SlideShare
      • 0 from embeds
    • Comments 0
    • Favorites 0
    • Downloads 44
    Most viewed embeds

    more

    All embeds

    less

    Flagged as inappropriate Flag as inappropriate
    Flag as inappropriate

    Select your reason for flagging this presentation as inappropriate. If needed, use the feedback form to let us know more details.

    Cancel
    File a copyright complaint
    Having problems? Go to our helpdesk?

    Categories